2026-10-19T01:36:24Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/177692026-10-18T20:49:43Zopenairedrivercom_ebyu_10000col_ebyu_10001

Therapeutic Effect of Thrombolytic Therapy on Motor Function Loss After Ischaemic Stroke: A Case StudyAKCAY, GUVENKarakoç, EsraÇamur, SenaAKTAŞ, FİLİZGenel ve Dahili TıpPatolojiKlinik NörolojiNörolojik BilimlerAnatomi ve MorfolojiStroke is a serious cerebrovascular disease that can cause disability and death if not treated with appropriate treatment methods at the right time. In ischaemic stroke, recombinant tissue plasminogen activator (rt-PA) treatment is effective in motor deficit recovery, especially in the first 4.5 hours. In this case study, rt-PA thrombolytic treatment of patients with motor deficit after acute ischaemic stroke aged 58 and 79 years was found to improve the loss of motor function.2024Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/17769https://doi.org/10.52827/hititmedj.1418809enHitit medical journal (Online)info:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/17769